The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10168 malaria professionals are enjoying the free benefits of MalariaWorld today

Mauritania

Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania

October 1, 2019 - 14:27 -- Open Access
Author(s): 
Oum kelthoum Mamadou Djigo, Mohamed Abdallahi Bollahi, Moina Hasni Ebou, Mohamed Salem Ould Ahmedou Salem, Rachida Tahar, Hervé Bogreau, Leonardo Basco, Ali Ould Mohamed Salem Boukhary
Reference: 
PLoS ONE 14(9): e0220977

Primaquine is recommended by the World Health Organization (WHO) for radical treatment of Plasmodium vivax malaria. This drug is known to provoke acute hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Due to lack of data on G6PD deficiency, the use of primaquine has been limited in Africa. In the present study, G6PD deficiency was investigated in blood donors of various ethnic groups living in Nouakchott, a P. vivax endemic area in Mauritania.

Country: 
Medical Condition: 

Malaria in three epidemiological strata in Mauritania

April 12, 2016 - 16:47 -- Open Access
Tags: 
Author(s): 
Mohamed Ouldabdallahi Moukah, Ousmane Ba, Hampaté Ba, Mohamed Lemine Ould Khairy, Ousmane Faye, Hervé Bogreau, Frédéric Simard and Leonardo K. Basco
Reference: 
Malaria Journal 2016 15:204, 12 April 2016

The results of the present study support the stratification of malaria in Mauritania. However, the Sahelian zone had the lowest malaria prevalence, while the Sahelo-Saharan zone had the highest malaria burden.

Country: 

Malaria in Mauritania: retrospective and prospective overview

March 5, 2015 - 17:51 -- Open Access
Tags: 
Author(s): 
Khadijetou Lekweiry, Mohamed Salem, Leonardo K Basco, Sébastien Briolant, Jamaleddine Hafid, Ali Boukhary
Reference: 
Malaria Journal 2015, 14:100 (4 March 2015)

Malaria has become a major public health problem in Mauritania since the 1990s, with an average of 181,000 cases per year and 2,233,066 persons at risk during 1995–2012.

Country: 

Polymorphism of the merozoite surface protein-1 block 2 region in Plasmodium falciparum isolates from Mauritania

January 27, 2014 - 14:14 -- Open Access
Author(s): 
Ahmedou Salem MS, Ndiaye M, OuldAbdallahi M, Lekweiry KM, Bogreau H, Konaté L, Faye B, Gaye O, Faye O, Mohamed Salem O Boukhary AO
Reference: 
Malaria Journal 2014, 13 :26 (23 January 2014)

The polymorphism of P. falciparum populations from Mauritania was high. Infection with multiple P. falciparum clones was observed, as well as a high multiplicity of infection reflecting both the high endemicity level and malaria transmission in Mauritania.

Country: 

Absence of dry season Plasmodium parasitaemia, but high rates of reported acute respiratory infection and diarrhoea in preschool-aged children in Kaedi, southern Mauritania

September 11, 2012 - 05:10 -- Patrick Sampao
Author(s): 
Touray S, Bâ H, Bâ O, Koïta M, Ould Ahmed Salem CB, Keïta M, Traoré D, Sy I, Winkler MS, Utzinger J, Cissé G
Reference: 
Parasites & Vectors 2012, 5:193 (7 September 2012)

MalariaWorldWe conducted a multipurpose cross-sectional survey in the city of Kaedi in April 2011 (dry season), assessing three major disease patterns, including malaria. Plasmodium spp. parasite rates were tested among children aged 6--59 months who were recruited from a random selection of households using a rapid diagnostic test and microscopic examination of Giemsa-stained thick and thin blood films.

Person: 
Country: 
Medical Condition: 

Malaria prevalence and morbidity among children reporting at health facilities in Nouakchott, Mauritania

November 14, 2011 - 13:47 -- Patrick Sampao
Author(s): 
Khadijetou Mint Lekweiry, Leonardo K. Basco, Ali O. Mohamed Salem O. Boukhary, et al.
Reference: 
Transactions of the Royal Society of Tropical Medicine and Hygiene, Volume 105, Issue 12, December 2011, Pages 727-733

MalariaWorldResults of the present study indicate that malaria is endemic in Nouakchott and that P. vivax is the principal causative agent.

Person: 
Country: 
City: 
Medical Condition: 

Open Access | Vivax malaria in Mauritania includes infection of a Duffy-negative individual

November 8, 2011 - 09:25 -- Kabogo Ndegwa
Author(s): 
Wurtz N, Lekweiry Mint K, Bogreau H, Pradines B, Rogier C, Salem Boukhary AO, Hafid JE, Ahmedou Salem MS, Trape J, Basco LK, Briolant S
Reference: 
Malaria Journal 2011, 10:336 (3 November 2011)

MalariaWorldThis study presents the Duffy blood group polymorphisms in Nouakchott City and demonstrates that in Mauritania, P. vivax is able to infect Duffy-negative patients.

Country: 
Medical Condition: 

Open Access | Short report: Distribution, host preference and infection rates of malaria vectors in Mauritania

December 14, 2009 - 10:34 -- Ingeborg van Schayk
Author(s): 
Dia I, Ba H, Mohamed SO, Diallo D, Lo B, Diallo M
Reference: 
Parasites & Vectors 2009, 2:61 (4 December 2009)

This study reports for the first time on the distribution, host preference and infection rates of malaria vectors in Mauritania.

Country: 
Medical Condition: 
Subscribe to RSS - Mauritania